Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data

Publisher： Karger

E-ISSN： 2296-5262|38|6|291-298

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.6, 2015-05, pp. : 291-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resistance to HER2-targeted therapy: mechanisms of trastuzumab resistance and possible strategies to overcome unresponsiveness to treatment

By Hubalek Michael  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 19-20, 2010-11 ,pp. : 506-512

Springer Publishing Company

Access to resources Recommend Favorite

The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence

By  

Reviews on Recent Clinical Trials, Vol. 13, Iss. 1, 2018-01 ,pp. : 61-68

Bentham Science Publishers

Access to resources Recommend Favorite

ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2392-2402

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies

By  

Oncology Research and Treatment, Vol. 37, Iss. 10, 2014-09 ,pp. : 584-589

Karger

Access to resources Recommend Favorite

Antifungal drug resistance among Candida species: mechanisms and clinical impact

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. S2, 2015-06 ,pp. : 2-13

John Wiley & Sons Inc

Access to resources Recommend Favorite